Tags: mental healthSchizophreniaCannabisanimal behavioranimals
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Oshan Jarow Vox Focus on consciousness, economics. Co-founder LE Possibility. Brooklyn, New York | Psychedelics can have enormous benefits, but the risks shouldn’t be ignored - about 1 year ago | |
| 2 | Judy George MedPage Today Medical reporter, writer. | ||
| 3 | Kristen Monaco MedPage Today | Long-Term Data Support Efficacy, Safety of New Schizophrenia Drug - about 2 months ago Assessing Tardive Dyskinesia Risk - 4 months ago Another Mid-Stage Psychedelic Win; Gun Suicides Reach High; Magnetic Seizure Therapy - about 1 year ago Psilocybin Shows Promise in Treatment-Resistant Bipolar Type II Depression - about 1 year ago U.S. Suicides Hit Record High; FDA Reviews Schizophrenia Drug; Psychology of Misinfo - about 1 year ago | |
| 4 | Michael DePeau-Wilson MedPage Today Enterprise Reporter. AI in Healthcare focus. Journalism alum. Not specified | Magnetic Stimulation Reduced Auditory Hallucinations in Patients With Schizophrenia - about 1 month ago Counterfeit Ozempic; Mary Lou Retton Discharged; No Such Thing as Free Will? - about 1 year ago | |
| 5 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
| 6 | Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois | ||
| 7 | The Conversation Science Alert Science news. Official account. Australia | What Is Alexithymia? A Guide to The Hidden Experience of Millions - about 2 months ago | |
| 8 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | ||
| 9 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | ||
| 10 | Clare Wilson New Scientist Science news source. Worldwide |